OxemiaTM (Desidustat) is an oral tablet formulation that is the first-in-India alternative to injectable erythropoietin-stimulating agents (ESAs)
First advanced hybrid closed-loop insulin pump system in India features automatic insulin delivery, automatic correction boluses, and bluetooth connectivity
Arctoris and Evariste Technologies announce a joint venture to develop novel small molecule kinase inhibitors for non-small cell lung cancer (NSCLC)
Taisho Pharmaceutical will bring its experience and expertise in the research and development of therapeutic products to the collaboration.
NATCO and Teva are launching these strengths of lenalidomide pursuant to a license of patents owned by Celgene
The approval marks the first-and-only immunotherapy-based treatment for use before surgery for non-small cell lung cancer
A simple blood test detects over 30 types of cancers
According to an Injury Surveillance Report by NCA last year, 14.75 % of players sustained shoulder injuries, 13.11% of players sustained knee injuries and almost 74 % players suffer from career-threatening Anterior Cruciate Ligament (ACL) injuries in the 1st two years of return to sport
Novel technology combines ACUVUE daily disposable contact lenses with an established antihistamine in FDA- first in its new category
Around 85% of ALS patients suffer from a progressive loss of bulbar functionality
Subscribe To Our Newsletter & Stay Updated
